Quidel's Solana Whooping Cough MDx Clears FDA

Jul 16, 2018

NEW YORK (GenomeWeb) – A molecular diagnostic assay from Quidel to detect bacterial strains that cause whooping cough has received 510(k) clearance from the US Food and Drug Administration, the firm announced today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Quidel's Solana Whooping Cough MDx Clears FDA

To read the full story....

Breaking News

Illumina to Acquire Grail for $8B in Cash and Stock

Scanwell Health Receives $1.6M NIH Grant to Develop At-Home Test for Chronic Kidney Disease

Yourgene Inks US Distribution Deal for Chemotoxicity Assay, Other Tests

Siemens Healthineers, Novartis Ink Deal to Develop Assays With Initial Focus on MS Therapeutics

FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

CDC Reverses Position, Says Asymptomatic Patients Should Be Tested for SARS-CoV-2

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

What's Popular?

FDA Publishes First Batch of SARS-CoV-2 MDx Limit of Detection Comparison Results

FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

Qiagen Acquires Remaining Stake in NeuMoDx Molecular for $248M

Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

DiaSorin Receives CE Mark to Use Saliva Samples With COVID-19 Test

Sponsorships